300086 康芝藥業
按盤價 
5.730 -0.540 (-8.612%)
5.730 -0.540 (-8.612%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -3.710 | -22.840 | -17.514 | -1.035 | -13.303 |
| 總資產報酬率 ROA (%) | -1.871 | -12.217 | -10.403 | -0.616 | -7.903 |
| 投入資產回報率 ROIC (%) | -2.387 | -14.815 | -11.989 | -0.700 | -8.946 | 邊際利潤分析 |
| 銷售毛利率 (%) | 54.730 | 54.201 | 55.043 | 57.255 | 50.796 |
| 營業利潤率 (%) | -19.087 | -55.202 | -45.682 | -1.193 | -39.834 |
| 息稅前利潤/營業總收入 (%) | -14.089 | -51.830 | -43.361 | 1.854 | -36.693 |
| 淨利潤/營業總收入 (%) | -23.145 | -50.208 | -47.637 | -2.902 | -36.949 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 143.897 | 71.225 | 71.608 | 8.556 | 69.002 |
| 價值變動淨收益/利潤總額(%) | 0.000 | 13.717 | 0.647 | 118.849 | 8.689 |
| 營業外收支淨額/利潤總額(%) | -0.019 | 0.834 | 4.294 | 15.753 | 3.661 | 償債能力分析 |
| 流動比率 (X) | 0.455 | 0.522 | 0.850 | 1.512 | 1.329 |
| 速動比率 (X) | 0.158 | 0.247 | 0.491 | 0.893 | 0.991 |
| 資產負債率 (%) | 48.141 | 48.564 | 42.276 | 36.830 | 40.768 |
| 帶息債務/全部投入資本 (%) | 27.708 | 28.470 | 28.340 | 24.881 | 30.931 |
| 股東權益/帶息債務 (%) | 233.141 | 225.108 | 231.128 | 284.242 | 209.659 |
| 股東權益/負債合計 (%) | 105.208 | 103.440 | 133.500 | 167.300 | 141.076 |
| 利息保障倍數 (X) | -2.821 | -13.511 | -9.920 | 0.567 | -7.883 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 41.251 | 40.516 | 78.217 | 45.688 | 74.092 |
| 存貨周轉天數 (天) | 451.546 | 292.959 | 361.355 | 248.551 | 251.465 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 21/09/2026 16:19 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
